Aigen Investment Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,034
| Closed | -$142K | – | 862 |
|
|
2024
Q1 | $142K | Buy |
+12,034
| New | +$142K | 0.03% | 582 |
|
|
2023
Q4 | – | Sell |
-31,695
| Closed | -$385K | – | 888 |
|
|
2023
Q3 | $385K | Buy |
+31,695
| New | +$385K | 0.07% | 447 |
|
|
2023
Q2 | – | Sell |
-21,401
| Closed | -$237K | – | 825 |
|
|
2023
Q1 | $237K | Buy |
+21,401
| New | +$237K | 0.03% | 487 |
|
|
2022
Q2 | – | Sell |
-12,095
| Closed | -$115K | – | 596 |
|
|
2022
Q1 | $115K | Buy |
+12,095
| New | +$115K | 0.02% | 491 |
|
|
2021
Q2 | – | Sell |
-22,827
| Closed | -$226K | – | 566 |
|
|
2021
Q1 | $226K | Buy |
+22,827
| New | +$226K | 0.03% | 504 |
|
|
2020
Q1 | – | Sell |
-2
| Closed | – | – | 1363 |
|
|
2019
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 1124 |
|